Augmentin Dosing for Severe Impetigo in a 6-Year-Old
For severe impetigo in a 6-year-old child, prescribe amoxicillin-clavulanate (Augmentin) at 25 mg/kg/day of the amoxicillin component divided into 2 doses, administered orally for 7–10 days. 1
Weight-Based Dosing Calculation
Assuming an average 6-year-old weighs approximately 20–25 kg, the standard dose translates to 250–312 mg of amoxicillin per dose, given twice daily. 1
Using the 875 mg/125 mg tablet formulation (if the child can swallow tablets), administer one-half tablet twice daily, providing approximately 437.5 mg amoxicillin per dose—slightly above the calculated requirement but within safe pediatric dosing ranges. 1
Alternatively, use the 250 mg/62.5 mg per 5 mL suspension: administer 5–6 mL twice daily to deliver 250–300 mg amoxicillin per dose. 1
Rationale for Systemic Therapy in Severe Impetigo
The IDSA guideline designates impetigo as severe when lesions are widespread, multilesional, or have failed topical therapy within 3–5 days. 1
Severe impetigo requires systemic antibiotics targeting both Staphylococcus aureus and Streptococcus pyogenes, the two predominant pathogens. 1, 2
Amoxicillin-clavulanate provides coverage against β-lactamase–producing S. aureus strains that are resistant to amoxicillin alone, making it superior to plain amoxicillin in clinical trials of severe pyoderma. 3, 4, 5
Evidence Supporting Amoxicillin-Clavulanate Efficacy
A randomized trial in 200 children with pyoderma (47% impetigo) demonstrated that amoxicillin-clavulanate achieved 96% clinical cure in severe cases, outperforming amoxicillin (90%), erythromycin (83%), and co-trimoxazole (52%). 3, 4
A double-blind study comparing amoxicillin alone versus amoxicillin-clavulanate in nonbullous impetigo showed significantly faster improvement (71% marked improvement at 2 days vs. 44% with amoxicillin) and fewer new lesions during treatment with the combination. 5
All S. aureus isolates in these studies were sensitive to amoxicillin-clavulanate but resistant to amoxicillin alone, confirming the clinical importance of the β-lactamase inhibitor. 5
Alternative Oral Antibiotics for Severe Impetigo
Cephalexin 25–50 mg/kg/day divided into 3–4 doses is an acceptable alternative for penicillin-allergic patients without immediate hypersensitivity reactions. 1
Clindamycin 20 mg/kg/day divided into 3 doses is recommended for patients with documented penicillin allergy or when MRSA is suspected. 1
Dicloxacillin 25–50 mg/kg/day in 4 divided doses is the oral agent of choice for methicillin-susceptible S. aureus in adults but is less commonly used in pediatrics due to dosing frequency. 1
Duration of Therapy and Monitoring
Treat for 7–10 days to ensure eradication of both staphylococcal and streptococcal pathogens. 1, 2
Reassess clinically after 48–72 hours; if no improvement occurs, consider switching to clindamycin or adding MRSA coverage if community prevalence is high. 1, 2
Instruct caregivers to administer the medication with food to minimize gastrointestinal side effects, particularly diarrhea (reported in 4–12% of pediatric patients). 6, 3
Common Pitfalls and Practical Considerations
Do not cap the dose at adult maximums for children >15 kg; always use weight-based dosing to avoid subtherapeutic exposure. 7
Ensure proper storage: amoxicillin-clavulanate suspension must be refrigerated after reconstitution and discarded after 10 days to maintain potency. 6, 8
Avoid topical antibiotics alone for severe impetigo; mupirocin and retapamulin are reserved for limited, mild lesions only. 1, 2
Counsel on infection control: good hand hygiene, washing contaminated objects, and keeping the child home from school for 12–24 hours after starting antibiotics reduce transmission. 2